These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 566110)

  • 21. Development of a method for the incorporation of substitution-inert metal ions into proteins. Site-specific modification of arsanilazotyrosine-248 carboxypeptidase A with cobalt(III).
    Urdea MS; Legg JI
    Biochemistry; 1979 Oct; 18(22):4984-91. PubMed ID: 41571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catalytic and conformational changes induced by limited subtilisin cleavage of bovine carboxypeptidase A.
    Solomon BM; Larsen KS; Riordan JF
    Biochemistry; 1990 Aug; 29(31):7303-9. PubMed ID: 1698455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of the structural difference between bovine blood coagulation factors X1 and X2 to tyrosine 18 in the activation peptide.
    Morita T; Jackson CM
    J Biol Chem; 1986 Mar; 261(9):4008-14. PubMed ID: 3949800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and crystallization of human carboxypeptidase A.
    Peterson LM; Sokolovsky M; Vallee BL
    Biochemistry; 1976 Jun; 15(12):2501-8. PubMed ID: 938622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azocarboxypeptidase: functional consequences of tyrosyl and histidyl modification.
    Sokolovsky M; Vallee BL
    Biochemistry; 1967 Mar; 6(3):700-8. PubMed ID: 6025557
    [No Abstract]   [Full Text] [Related]  

  • 26. Physicochemical and kinetic properties of iodinated yeast 3-phosphoglycerate kinase.
    Roustan C; Fattoum A; Pradel LA
    Biochemistry; 1976 May; 15(10):2172-7. PubMed ID: 776218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The status of tyrosyl residues in a Formosan cobra cardiotoxin.
    Hung MC; Pan YH; Cheng KL; Chen YH
    Biochim Biophys Acta; 1978 Aug; 535(2):178-87. PubMed ID: 28149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the reaction of papain and succinylpapin with diazo-1-H-tetrazole.
    Löffler HG; Schneider FR
    Biochim Biophys Acta; 1975 Mar; 386(1):221-32. PubMed ID: 236020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Similarities between the conformation of arsanilazotyrosine 248 of carboxypeptidase A in the crystalline state and in solution.
    Quiocho FA; McMurray CH; Lipscomb WN
    Proc Natl Acad Sci U S A; 1972 Oct; 69(10):2850-4. PubMed ID: 4507609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1H-n.m.r. studies of the isolated activation segment from pig procarboxypeptidase A.
    Vendrell J; Avilés FX; Vilanova M; Turner CH; Crane-Robinson C
    Biochem J; 1990 Apr; 267(1):213-20. PubMed ID: 2327981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the catalytic histidine residue participating in the charge-relay system of carboxypeptidase Y.
    Jung G; Ueno H; Hayashi R; Liao TH
    Protein Sci; 1995 Nov; 4(11):2433-5. PubMed ID: 8563642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circular dichroism-inhibitor titrations of arsanilazotyrosine-248 carboxypeptidase A.
    Johansen JT; Klyosov AA; Vallee BL
    Biochemistry; 1976 Jan; 15(2):296-303. PubMed ID: 1247518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of pH on the structure and function of carboxypeptidase A: crystallographic studies.
    Shoham G; Rees DC; Lipscomb WN
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7767-71. PubMed ID: 6595659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenicity of bovine ribonuclease modified at tyrosine or arginine residues.
    van der Zee R; Duisterwinkel FJ; Welling GW
    Eur J Biochem; 1977 Jul; 77(1):125-31. PubMed ID: 409601
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemical modification of human alpha 1-proteinase inhibitor by tetranitromethane. Structure-function relationship.
    Mierzwa S; Chan SK
    Biochem J; 1987 Aug; 246(1):37-42. PubMed ID: 3499901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the primary structure of pituitary bovine growth hormone.
    Gráf L; Li CH
    Biochem Biophys Res Commun; 1974 Jan; 56(1):168-76. PubMed ID: 4856718
    [No Abstract]   [Full Text] [Related]  

  • 37. Inactivation of horse liver alcohol dehydrogenase by modification of cysteine residue 174 with diazonium-1H-tetrazole.
    Sogin DC; Plapp BV
    Biochemistry; 1976 Mar; 15(5):1087-93. PubMed ID: 1252428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional arginyl residues in carboxypeptidase A. Modification with butanedione.
    Riordan JF
    Biochemistry; 1973 Sep; 12(20):3915-23. PubMed ID: 4355543
    [No Abstract]   [Full Text] [Related]  

  • 39. Crystal structure of an oligomer of proteolytic zymogens: detailed conformational analysis of the bovine ternary complex and implications for their activation.
    Gomis-Rüth FX; Gómez-Ortiz M; Vendrell J; Ventura S; Bode W; Huber R; Avilés FX
    J Mol Biol; 1997 Jun; 269(5):861-80. PubMed ID: 9223647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of glutathione S-transferases by nitric oxide-derived oxidants: exploring a role for tyrosine nitration.
    Wong PS; Eiserich JP; Reddy S; Lopez CL; Cross CE; van der Vliet A
    Arch Biochem Biophys; 2001 Oct; 394(2):216-28. PubMed ID: 11594736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.